Compare VVV & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVV | MMED |
|---|---|---|
| Founded | 1866 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.3B |
| IPO Year | 2016 | 2026 |
| Metric | VVV | MMED |
|---|---|---|
| Price | $38.33 | $16.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | ★ $40.00 | $22.56 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.86 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $2,285,000,000.00 | N/A |
| Revenue This Year | $20.80 | $15.99 |
| Revenue Next Year | $10.50 | $10.00 |
| P/E Ratio | $433.67 | ★ N/A |
| Revenue Growth | ★ 9.64 | N/A |
| 52 Week Low | $28.50 | $10.65 |
| 52 Week High | $41.33 | $17.86 |
| Indicator | VVV | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 60.01 |
| Support Level | $37.01 | $14.70 |
| Resistance Level | $39.56 | N/A |
| Average True Range (ATR) | 1.03 | 0.87 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 34.20 | 57.65 |
Valvoline Inc provides automotive preventive maintenance through retail stores across the U.S. and Canada, offering approximately 15-minute stay-in-your-car oil changes, battery, bulb, and wiper replacements, tire rotations, and other manufacturer-recommended maintenance. Its full-service oil changes include Valvoline oil, a new oil filter, chassis lubrication, and an 18-point maintenance check. The Company provides differential fluid, fuel system cleaning, headlight and taillight replacement, radiator service, transmission service, air conditioning, and air filter replacement. It operates and franchises approximately 2,200 Valvoline Instant Oil Change and Valvoline Great Canadian Oil Change retail locations. The majority of revenue is generated from the United States of America.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.